ARTA to FDA: Expedite application process for Ivermectin

29 March 2021 – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for the possible treatment of COVID-19 symptoms. This, after the FDA announced earlier today that doctors and hospitals may now apply for.. read more